"Myocarditis" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Inflammatory processes of the muscular walls of the heart (MYOCARDIUM) which result in injury to the cardiac muscle cells (MYOCYTES, CARDIAC). Manifestations range from subclinical to sudden death (DEATH, SUDDEN). Myocarditis in association with cardiac dysfunction is classified as inflammatory CARDIOMYOPATHY usually caused by INFECTION, autoimmune diseases, or responses to toxic substances. Myocarditis is also a common cause of DILATED CARDIOMYOPATHY and other cardiomyopathies.
| Descriptor ID |
D009205
|
| MeSH Number(s) |
C14.280.238.625
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Myocarditis".
Below are MeSH descriptors whose meaning is more specific than "Myocarditis".
This graph shows the total number of publications written about "Myocarditis" by people in this website by year, and whether "Myocarditis" was a major or minor topic of these publications.
View timeline visualization
| Year | Major Topic | Minor Topic | Total |
|---|
| 1995 | 2 | 0 | 2 |
| 1996 | 4 | 2 | 6 |
| 1998 | 1 | 1 | 2 |
| 1999 | 2 | 2 | 4 |
| 2000 | 4 | 3 | 7 |
| 2001 | 4 | 0 | 4 |
| 2002 | 4 | 2 | 6 |
| 2003 | 8 | 1 | 9 |
| 2004 | 4 | 4 | 8 |
| 2005 | 2 | 1 | 3 |
| 2006 | 9 | 3 | 12 |
| 2007 | 4 | 1 | 5 |
| 2008 | 10 | 2 | 12 |
| 2009 | 13 | 2 | 15 |
| 2010 | 9 | 2 | 11 |
| 2011 | 6 | 1 | 7 |
| 2012 | 7 | 1 | 8 |
| 2013 | 5 | 4 | 9 |
| 2014 | 5 | 3 | 8 |
| 2015 | 2 | 4 | 6 |
| 2016 | 8 | 1 | 9 |
| 2017 | 9 | 0 | 9 |
| 2018 | 9 | 1 | 10 |
| 2019 | 13 | 3 | 16 |
| 2020 | 18 | 3 | 21 |
| 2021 | 23 | 1 | 24 |
| 2022 | 30 | 1 | 31 |
| 2023 | 23 | 0 | 23 |
| 2024 | 5 | 1 | 6 |
| 2025 | 1 | 0 | 1 |
Below are the most recent publications written about "Myocarditis" by people in Profiles.
-
Review of Immunologic Manifestations of COVID-19 Infection and Vaccination. Rheum Dis Clin North Am. 2025 Feb; 51(1):111-121.
-
Unveiling Cellular Identities and Gene Expression Pathways in Overlapping Myocarditis and Myositis. Cancer Immunol Res. 2024 Aug 01; 12(8):954-955.
-
Immune-checkpoint inhibitor-mediated myocarditis: CTLA4, PD1 and LAG3 in the heart. Nat Rev Cancer. 2024 Aug; 24(8):540-553.
-
Long-term cardiovascular inflammation and fibrosis in a murine model of vasculitis induced by Lactobacillus casei cell wall extract. Front Immunol. 2024; 15:1411979.
-
Autoimmune Myocarditis, Old Dogs and New Tricks. Circ Res. 2024 Jun 07; 134(12):1767-1790.
-
Eosinophilic myocarditis: systematic review. Heart. 2024 Apr 25; 110(10):687-693.
-
Lymphangiogenesis in Rheumatic Heart Valve Disease: A New Factor in the Pathogenic Conundrum. Arterioscler Thromb Vasc Biol. 2024 04; 44(4):822-825.
-
Cardiovascular events after cancer immunotherapy as oncologic emergencies: Analyses of 610 head and neck cancer patients treated with immune checkpoint inhibitors. Head Neck. 2024 03; 46(3):627-635.
-
Reply: Association of Adverse Events With the Different Diagnostic Schemes of Cardiac Sarcoidosis. JACC Clin Electrophysiol. 2023 12; 9(12):2662-2663.
-
Gene therapy vector-related myocarditis. Int J Cardiol. 2024 Mar 01; 398:131617.